TABLE 8

FDA Indications for Oral Formulations of Mood Stabilizers and Atypical Antipsychotics

MedicationBipolar disorderSchizophreniaIrritability associated with autismNonmental healthAll adult mental health
Mood stabilizer
 Lithium (Eskalith)Mania, ages 12–17Mania
 Divalproex (Depakote)Seizures, ages 0–17Mania
 Lamotrigine (Lamictal)Seizures, ages 2–17Bipolar maintenance
 Carbamazepine (Tegretol)Seizures, ages 0–17; trigeminal neuralgia
 Oxcarbazepine (Trileptal)Seizures, ages 2–17
 Gabapentin (Neurontin)Seizures, ages 3–17
 Topiramate (Topamax)Seizures, ages 2–17
Atypical antipsychotics
 Aripiprazole (Abilify)Manic and mixed episodes, ages 10–17Ages 13–17Ages 6–17Bipolar mania, schizophrenia, adjunctive for major depression
 Risperidone (Risperdal)Manic and mixed episodes, ages 10–17Ages 13–17Ages 5–16Schizophrenia, bipolar manic and mixed episodes
 Olanzapine (Zyprexa)Manic and mixed episodes, ages 13–17Ages 13–17Schizophrenia, bipolar manic and mixed episodes, bipolar and resistant depression (in combination with fluoxetine)
 Quetiapine (Seroquel)Manic episodes, ages 10–17Ages 13–17Schizophrenia, bipolar mania, bipolar depression
 Ziprasidone (Geodon)Schizophrenia, bipolar manic and mixed episodes, bipolar maintenance
 Paliperidone (Invega)Schizophrenia, schizoaffective disorder
 Clozapine (Clozaril)Schizophrenia, schizoaffective disorder
 Asenapine (Saphris)Schizophrenia, bipolar manic and mixed episodes
 Iloperidone (Fanapt)Schizophrenia
 Lurasidone (Latuda)Schizophrenia